Image FREESTOCKS/UNSPLASH Opinion: The Public Is Unified On Lowering Drug Prices. Why Are Leaders Settling For Less? PhRMA regards drug price negotiation for Medicare as an existential threat to its business — potentially costing billions. Nov 18, 2021 Subscribe to profit